RFG
GSK icon

Range Financial Group’s GSK GSK Stock Holding History

Range Financial Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$884K Buy
16,868
+109
+0.7% +$5.76K 0.24% 107
2026
Q1 		$925K Sell
16,759
-281
-2% -$15.2K 0.31% 95
2025
Q4 		$836K Buy
17,040
+515
+3% +$24K 0.29% 101
2025
Q3 		$713K Sell
16,525
-673
-4% -$26.3K 0.26% 107
2025
Q2 		$660K Buy
17,198
+8,063
+88% +$308K 0.26% 106
2025
Q1 		$354K Buy
9,135
+652
+8% +$23.9K 0.16% 135
2024
Q4 		$287K Buy
+8,483
New +$305K 0.13% 154
2024
Q3 		– Sell
-10,895
Closed -$419K – 121
2024
Q2 		$419K Sell
10,895
-124
-1% -$5.22K 0.21% 119
2024
Q1 		$472K Buy
11,019
+1,117
+11% +$46.1K 0.25% 114
2023
Q4 		$367K Sell
9,902
-870
-8% -$31.2K 0.22% 122
2023
Q3 		$390K Sell
10,772
-501
-4% -$17.8K 0.26% 113
2023
Q2 		$402K Sell
11,273
-135
-1% -$4.84K 0.26% 121
2023
Q1 		$406K Buy
11,408
+1,889
+20% +$66.1K 0.27% 122
2022
Q4 		$334K Sell
9,519
-1,197
-11% -$39.9K 0.23% 142
2022
Q3 		$315K Buy
10,716
+1,473
+16% +$55.8K 0.24% 128
2022
Q2 		$503K Sell
9,243
-208
-2% -$11.5K 0.37% 110
2022
Q1 		$515K Buy
9,451
+154
+2% +$8.37K 0.33% 107
2021
Q4 		$512K Buy
9,297
+111
+1% +$5.77K 0.34% 105
2021
Q3 		$439K Buy
9,186
+87
+1% +$4.37K 0.32% 107
2021
Q2 		$453K Buy
9,099
+329
+4% +$15.8K 0.33% 95
2021
Q1 		$391K Buy
+8,770
New +$398K 0.36% 103

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
BB
Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return
KIC
Keating Investment Counselors Delray Beach, Florida $364M AUM 22.11% 1-Year Est. Return
GHAM
Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return
AWAG
ARS Wealth Advisors Group St. Petersburg, Florida $1.28B AUM 24.51% 1-Year Est. Return
HAI
Hennessy Advisors Inc Novato, California $3.13B AUM 77.26% 1-Year Est. Return

Range Financial Group's GSK Position: Q2 2026 in Review

Range Financial Group increased its GSK (GSK) stake by 0.65% in Q2 2026, buying an estimated $5.76K and bringing the position to 16,868 shares worth $884K. The position accounts for 0.24% of the portfolio, ranked #107.

Range Financial Group first reported a position in GSK in Q1 2021 and has held it in 21 quarters since. The position peaked at $925K in Q1 2026. 161 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Range Financial Group held 16,868 shares of GSK worth $884K as of Q2 2026.
  • Range Financial Group bought 109 GSK shares in Q2 2026, an estimated $5.76K.
  • GSK made up 0.24% of Range Financial Group's portfolio in Q2 2026, its #107 holding.
  • Range Financial Group first reported a position in GSK in Q1 2021 and has held it in 21 quarters since.
  • Range Financial Group's GSK position peaked at $925K in Q1 2026.
  • 161 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Range Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.